Abstract
Background
Medication errors may produce severe toxicity resulting in hospitalization. This can be compounded if the physician obtains the wrong concentration from a reference manual and a pharmacy miscalculates the conversion. We report a child presenting with ileus, hypothermia and lethargy after receiving supratherapeutic dosing of phenytoin after a concentration miscalculation.
Case Report
A one-month-old infant presented to the Emergency Department with progressive worsening of abdominal distension, diminished activity, and a one day history of difficulty feeding secondary to a decreased level of consciousness. The past medical history was significant for neonatal Group B Strep meningitis with seizures. Among the child’s discharge medications was a prescription for phenytoin (30 mg/5 mL) 2.5 cc by mouth three times daily. On exam, the child was hypothermic with pink mottled skin, poor responsiveness, prolonged capillary refill, abdominal distension with hypoactive bowel sounds, and a dysconjugate gaze. The Initial phenytoin serum concentration was 91.8 mcg/mL. She was admitted to the PICU and was started on ampicillin and cefotaxime for R/O sepsis. Phenytoin was withheld and subsequent serum concentrations revealed an extremely slow elimination (mcg/mL vs. time pair coordinates were 78.2/13.3h; 74.3/62.3h; 43.7/109.6h; 10.8/160.9h) reflecting zero-order kinetics. Post discontinuing antibiotics, phenytoin levels decreased at rates expected. She was discharged after resolution of symptoms. The MD who had written the phenytoin prescription had based it on theHarriet Lane Handbook, 2000 Ed. The 30 mg/5 mL formulation has been unavailable in the US for several years. A community pharmacy substituted the 125 mg/5 mL formulation, but miscalculated the dosage to be 1.6 cc (40 mg) tid.
Conclusions
Abdominal distension and ileus may be presenting symptoms in children at toxic phenytoin levels. Ampicillin and cefotaxime may effect the elimination rate of phenytoin at such levels. We report one of the highest phenytoin levels recorded after therapeutic misadventure. Physicians must be aware of inaccuracies in reference manuals that may result in dosing errors.
Article PDF
Similar content being viewed by others
References
Anonymous. American Academy of Pediatrics: Committee on Drugs and Committee on Hospital Care. Pediatrics.1998;102:428.
Sharfstein J, Agrawal D, Jeffrey P. Letter to the editor. Pediatrics.1998;102:1223.
Wyte C, Berk WA. Severe oral phenytoin overdose does not cause cardiovascular mortality. Ann Emerg Med.1991;20:508.
Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (Part II). Clin Pharmacokinet.1990;18:131.
Sarich T, Wright JM. Hypothyroxinemia and phenytoin toxicity: A vicious circle. Drug Metabol Drug Interact.1996;13:155.
Zhu SQ, Liu XM, Ruan XZ, Cai Z. Changes of thyroid hormone levels in epileptic patients. J Tongji Med Univ.1994;14:119.
Bassotti G, Pagliacci MC, Nicoletti I, Pelli MA, Morelli A. Intestinal pseudo-obstruction secondary to hypothyroidism. Importance of small bowel manometry. J Clin Gastroenterol.1992;14:56.
Goto S, Billmire DF, Grosfeld JL. Hypothyroidism impairs colonic motility and function. An experimental study in the rat. Eur J Pediatr Surg.1992;2:16.
Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Clin Pharmacokinet.1995;29:341.
Painter MJ, Minnigh MB, Gaus L, Scher M, Brozanski B, Alvin J. Neonatal phenobarbital and phenytoin binding profiles. J Clin Pharmacol.1994;34:312.
Leeder JS, Kearns GL. Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am.1997;44:55.
Bachmann K, Schwartz JI, Forney RB, Jaurgeui L. Single dose phenytoin clearance during erythromycin treatment. Research Communications in Chemical Pathology and Pharmacology.1984;46:207.
Tucker RM, Denning DW, Hanson LH, Rinaldi MG, Graybill JR, Sharkey PK, et al. Interaction of azoles with rifampin, phenytoin, and carbamazepine: In vitro and clinical observations. Clin Infect Dis.1992;14:165.
Rose JQ, Choi HK, Schentag JJ, Kinkel WR, Jusko WJ. Intoxication caused by interaction of chloramphenicol and phenytoin. JAMA.1977;237:2630.
Bint AJ, Burtt I. Adverse antiobiotic drug interactions. Drugs.1980;20:57.
Chandra RS, Dalvi SS, Powar HS, Karnad PD, Kshirsagar NA. Phenytoin toxicity due to rifampicin induced hepatic dysfunction. JAPI.1993;41:536.
Dasgupta A, Dennen DA, Dean R, McLawhorn RW. Displacement of phenytoin from serum protein carriers by antibiotics: Studies with ceftriaxone, nafcillin, and sulfamethoxazole. Clin Chem.1991;37:98.
Dasgupta A, Sperelakis A, Mason A, Dean R. Phenytoin-oxacillin interactions in normal and uremic sera. Pharmacother.1997;17:375.
Arimori K, Nakano M, Otagiri M, Uekama K. Effects of penicillins on binding of phenytoin to plasma proteins in vitro and in vivo. Biopharm Drug Dispos.1984;5:219–27.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lowry, J.A., Vandover, J.C., DeGreeff, J. et al. Unusual presentation of iatrogenic phenytoin toxicity in a newborn. J. Med. Toxicol. 1, 26–29 (2005). https://doi.org/10.1007/BF03160902
Issue Date:
DOI: https://doi.org/10.1007/BF03160902